Early diagnosis of maple syrup urine disease using polymerase chain reaction‐based mutation detection

@article{Silao2008EarlyDO,
  title={Early diagnosis of maple syrup urine disease using polymerase chain reaction‐based mutation detection},
  author={Catherine Lynn Silao and Carmencita Padilla and Masafumi Matsuo},
  journal={Pediatrics International},
  year={2008},
  volume={50}
}
Background: Maple syrup urine disease (MSUD) is an autosomal recessive disorder caused by defective activity of the branched‐chain α‐ketoacid dehydrogenase enzyme complex. Early diagnosis and management of MSUD are imperative for preventing permanent neurological impairments. In the Philippines, a 4.7 kb deletion in the dihydrolipoamide branched‐chain transacylase E2 (DBT) gene has been commonly identified in MSUD patients. Polymerase chain reaction (PCR) amplification of a junction fragment… 
Pregnancy in an adolescent with maple syrup urine disease: Case report
Quantification of branched-chain amino acids in blood spots and plasma by liquid chromatography tandem mass spectrometry for the diagnosis of maple syrup urine disease.
TLDR
An LC-MS/MS assay for the diagnosis of MSUD is developed that is amenable to high-throughput formats due to the minimal sample prep required and robust, precise, and accurate.
Maple Syrup Urine Disease
TLDR
Adolescents and adults with MSUD are at increased risk for attention-deficit/hyperactivity disorder, depression, and anxiety disorders and can be treated successfully with standard psychostimulant and antidepressants.
Genetics and genomic medicine in the Philippines
TLDR
Genetics and genomic medicine in the Philippines is studied to find out if there are any commonalities in the treatment of infectious diseases and in particular in the management of central nervous system disorders.

References

SHOWING 1-9 OF 9 REFERENCES
Maple syrup urine disease: identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population.
TLDR
It is suggested that a limited number of mutations might underlie MSud in the AJ population, potentially facilitating prenatal diagnosis and carrier detection of MSUD in this group.
Maple syrup urine disease in the Austronesian aboriginal tribe Paiwan of Taiwan: a novel DBT (E2) gene 4.7 kb founder deletion caused by a nonhomologous recombination between LINE-1 and Alu and the carrier-frequency determination
TLDR
This is the first comprehensive genetics study of MSUD in the Austronesian tribal groups as well as in Taiwan, and identifies a novel E2 4.7 kb deletion as a rare nonhomologous recombination of the long interspersed nuclear elements 1 (LINE-1) in intron 10 and the Alu in the 3′ UTR of the E2 gene from three classic MSUD patients of theAustronesian aboriginal tribe Paiwan in Taiwan.
Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity.
TLDR
It is suggested that one component of the pathophysiological mechanism for the acute neurotoxic effects in this disorder is related to a defect in glutamate, glutamine and gamma-aminobutyric acid (GABA) production.
Intellectual outcome in children with maple syrup urine disease.
Management of acute metabolic decompensation in maple syrup urine disease: A multi‐center study
TLDR
Therapeutic modalities in acute metabolic decompensation in maple syrup urine disease are variable, and outcomes of each therapeutic measure have been known only individually.
Diagno - sis of MSUD by newborn screening allows early intervention without extraneous detoxifi cation
  • Mol . Genet . Metab
  • 2005
Maple syrup urine disease : Domain structure , mutations and exon skipping in the dihydrolipoyl transacylase ( E 2 ) component of the branched - chain keto aicd dehydrogenase complex
  • Mol . Biol . Med
  • 1991